A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis

Recruiting

Phase 2

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative ColitisA Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis

Sponsor:

Sanofi

Code:

NCT06867094

Conditions

Colitis Ulcerative

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

SAR441566

SAR441566 matching Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Sanofi on 2025-03-25.